Articles |

Introduction*: Asthma in the New Millennium FREE TO VIEW

Richard J. Martin, MD; Monica Kraft, MD
Author and Funding Information

*From the National Jewish Medical and Research Center, University of Colorado Health Science Center, Denver, CO.

Correspondence to: Richard J. Martin, MD, National Jewish Medical and Research Center, University of Colorado Health Science Center, 1400 Jackson St, Denver, CO 80206.

Chest. 2003;123(3_suppl):339S. doi:10.1378/chest.123.3_suppl.339S
Text Size: A A A
Published online

45th Annual Thomas L. Petty Aspen Lung Conference was held June 5 to 8, 2002. The title the conference was “Asthma in the New Millennium.” In planning this meeting, the organizers realized that the “explosion” of new information in regard to the pathophysiology and therapy for asthma would bring cutting edge scientific exchange throughout the sessions. This Aspen Lung Conference was planned with an emphasis on the basic and translational sciences, but also included new and novel therapies for asthma. The conference attendance reached another all-time high, which included scientists from 13 different countries. This, indeed, led to the excellent exchange of ideas and new information at an exceptionally high level.

The state-of-the-art asthma presentations focused on the biology of inflammation, the distal lung, functional consequences of airway structural changes, genetics/genomics, the epithelium, infection and asthma, airway smooth muscle, nocturnal asthma, severe asthma, bronchial hyperresponsiveness, airway remodeling, pediatric aspects, and new and exploratory therapies. There were a large number of high-quality poster presentations and 19 oral abstract presentations covering a variety of novel and late-breaking research. Always stressed at the Aspen Lung Conference are the discussion sessions after the state-of-the-art and abstract presentations. The interactions were always lively and challenging. The conference summarizer, Jeffrey M. Drazen, MD, eloquently put all this information together and challenged all of us to define asthma phenotypes and genotypes for better future therapies.


We thank the Francis Family Foundation for their continued support of the Parker B. Francis Lectureship. We also greatly appreciate the generous support of all the sponsors of this year’s conference.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543